August 22, 2014

Mylan on Friday announced the launch of potassium chloride extended-release tablets USP in 600-mg and 750-mg dosage strengths.

August 21, 2014

There are a number of growth drivers across the digestives space, starting with the biggest proton-pump inhibitor to make its way from behind the pharmacy bench to over-the-counter aisles since the original “Purple Pill” was switched in 2003.

August 20, 2014

Women’s desire for smooth, flawless skin doesn’t stop at the neck, and that’s especially true for mothers-to-be.

August 20, 2014

Kiss My Face introduced a new range of sun care options, which includes an expansion of its specialty sun offerings.

August 20, 2014

In May 2014, Pfizer introduced Nexium 24HR, one of the top-selling acid blockers, over the counter in the United States.

August 20, 2014

Coty’s Sally Hansen brand is looking to revolutionize the at-home gel manicure segment with its new Miracle Gel.

August 20, 2014

Researchers at the University of California, San Diego School of Medicine concluded that aspirin, in addition to preventing pain and inflammation, actually helps hasten the end of inflammation in a study published this week in the online early edition of PNAS.

August 20, 2014

Pfizer successfully switched Nexium to over-the-counter in late May, and with that brought a $6 billion book of prescription business to antacid aisles, according to IMS Health data compiled over 2012.

August 20, 2014

Sales of all vitamins are up slightly by 0.9% to $6.4 billion, according to IRI for the 52 weeks ended June 15 across total U.S. multi-outlets.

August 20, 2014

GM Pharmaceuticals recently launched 8-oz. bottles of its liquid pain reliever, VanaPain, which includes 16 servings of its daytime pain reliever and eight servings of its nighttime pain reliever.

August 14, 2014

Amneal Pharmaceuticals announced four new additions to its portfolio of generic drugs, which represent multiple therapeutic categories and account for $900 million annually in U.S. sales, the company said, citing data from IMS Health.

August 14, 2014

The Food and Drug Administration has announced approval for Belsomra (suvorexant) tablets, which are used to treat insomnia.

August 14, 2014

Procter & Gamble on Thursday announced it has teamed up with NFL Hall of Famer Dan Hampton to close out the Zero Burn Summer Barbeque Event Tour by making its way to the Chicago Air and Water Show on Aug. 17.

August 12, 2014

Sanofi on Tuesday announced that it has launched an authorized generic version of Eloxatin (oxaliplatin injection) through Winthrop U.S., the company’s generics division. 

August 11, 2014

The recent release of Colgate Total’s application submitted to the Food and Drug Administration, which included 35 pages summarizing toxicology studies on triclosan, is raising some eyebrows as some are wondering if the FDA did its due diligence in approving Total 17 years ago, according to a report from Bloomberg Businessweek.

August 11, 2014

Mylan announced the launch of capecitabine tablets USP in 150-mg and 500-mg dosage strengths, a generic version of Xeloda tablets from Genentech.

August 5, 2014

Lannett Co. on Monday announced that its abbreviated new drug application for oxycodone hydrochloride capsules, 5 mg, has been approved by the Food and Drug Administration.

August 4, 2014

Gummy vitamins continues to be a fast-moving subsegment within multivitamins, Jim Craigie, Church & Dwight executive chairman and CEO, told analysts Friday. 

August 4, 2014

Target is gearing up for fall with the launch of the Pixi by Petra collection for fall 2014 developed by makeup artist Petra Strand.

July 31, 2014

Teva Pharmaceuticals on Thursday announced results for second-quarter 2014, which included revenues of $5 billion, an increase of 2% compared with the same period last year.

July 30, 2014

A new study published in the July issue of the Journal of Bone and Mineral Research found no increased risk of coronary heart disease or all-cause mortality in post-menopausal women supplementing with calcium and vitamin D.

July 24, 2014

The Food and Drug Administration approved Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended-release tablets), a long-acting opioid analgesic.

July 23, 2014

Mylan on Wednesday announced that U.S. District Court for the district of New Jersey granted a temporary restraining order against Apotex Inc. and Apotex Corp. relating to Paroxetine CR.

July 22, 2014

The Food and Drug Administration has granted tentative approval to Teva Pharmaceutical for abacavir sulfate and lamivudine tablets, according to agency records.